3.06
price up icon7.18%   0.205
after-market Handel nachbörslich: 3.04 -0.02 -0.65%
loading

Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten

pulisher
08:59 AM

Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock - The Manila Times

08:59 AM
pulisher
08:55 AM

$30M Stock Offering: Cognition Therapeutics Advances Phase 3 Programs for Neurodegenerative Drug - Stock Titan

08:55 AM
pulisher
08:53 AM

Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock - GlobeNewswire Inc.

08:53 AM
pulisher
02:06 AM

How to manage a losing position in Cognition Therapeutics Inc.2025 Bull vs Bear & AI Powered Market Trend Analysis - Newser

02:06 AM
pulisher
01:11 AM

Cognition Therapeutics Inc. stock trend outlook and recovery pathWeekly Trend Report & Accurate Intraday Trading Signals - Newser

01:11 AM
pulisher
12:41 PM

Can Cognition Therapeutics Inc. hit a new high this monthJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - Newser

12:41 PM
pulisher
11:33 AM

Does Cognition Therapeutics Inc. show high probability of reboundJuly 2025 Breakouts & High Conviction Trade Alerts - Newser

11:33 AM
pulisher
08:01 AM

Cognition Therapeutics Inc. stock retracement – recovery analysisOil Prices & Fast Entry and Exit Trade Plans - Newser

08:01 AM
pulisher
07:26 AM

Automated trading signals detected on Cognition Therapeutics Inc.Entry Point & AI Powered Buy/Sell Recommendations - Newser

07:26 AM
pulisher
06:30 AM

Cognition Therapeutics regains Nasdaq compliance with $1 share price By Investing.com - Investing.com Canada

06:30 AM
pulisher
05:33 AM

Is Cognition Therapeutics Inc. still worth holding after the dipQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser

05:33 AM
pulisher
05:12 AM

Cognition Therapeutics shares rise 1.58% premarket after regaining compliance with Nasdaq. - AInvest

05:12 AM
pulisher
02:50 AM

Cognition Therapeutics regains Nasdaq compliance on $1.00 bid price rule - MSN

02:50 AM
pulisher
01:30 AM

Using economic indicators to assess Cognition Therapeutics Inc. potentialMarket Risk Report & Verified Technical Trade Signals - Newser

01:30 AM
pulisher
Aug 26, 2025

Cognition Therapeutics regains Nasdaq compliance with $1 share price - Investing.com India

Aug 26, 2025
pulisher
Aug 26, 2025

What technical models suggest about Cognition Therapeutics Inc.’s comebackWeekly Trade Summary & AI Powered Buy and Sell Recommendations - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics Regains Nasdaq Compliance - TipRanks

Aug 26, 2025
pulisher
Aug 26, 2025

Volatility clustering patterns for Cognition Therapeutics Inc.Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price Rule - MarketScreener

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics: A Nasdaq-Compliant Biotech Poised to Disrupt Alzheimer's Therapeutics - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics regains compliance with Nasdaq minimum bid price requirement - MarketScreener

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Aug 26, 2025
pulisher
Aug 26, 2025

Neurodegenerative Drug Developer Cognition Therapeutics Maintains Nasdaq Listing After Price Recovery - Stock Titan

Aug 26, 2025
pulisher
Aug 26, 2025

How moving averages guide Cognition Therapeutics Inc. tradingQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Real time scanner hits for Cognition Therapeutics Inc. explained2025 Price Targets & Scalable Portfolio Growth Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition Therapeutics Inc. Faces Market Upheaval Amidst Strategic Developments - StocksToTrade

Aug 26, 2025
pulisher
Aug 26, 2025

Earnings Chart Overlay Points to Cognition Therapeutics Inc. Upside getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 26, 2025
pulisher
Aug 26, 2025

Trend analysis for Cognition Therapeutics Inc. this weekMarket Performance Summary & Accurate Trade Setup Notifications - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Cognition: Zervimesine AD Treatment Program FDA Alignment Means "Strong Buy" Rating (NASDAQ:CGTX) - Seeking Alpha

Aug 26, 2025
pulisher
Aug 26, 2025

How high can Cognition Therapeutics Inc. stock goRate Cut & Consistent Return Strategy Ideas - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Identifying reversal signals in Cognition Therapeutics Inc.Fed Meeting & Accurate Entry/Exit Alerts - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Agitation in Alzheimer’s Disease Market: Epidemiology, Pipeline, Companies Working, DelveInsight | Eli Lilly and Co, BioVie Inc, AB Science SA, Annovis Bio Inc, Cognition Therapeutics Inc, Coya Therap - Barchart.com

Aug 25, 2025
pulisher
Aug 25, 2025

Leading vs lagging indicators on Cognition Therapeutics Inc. performanceTrade Risk Report & Weekly Top Gainers Trade List - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Cognition Therapeutics shares rise 1.82% after-hours following positive clinical data presentations by Stoke Therapeutics and Biogen. - AInvest

Aug 25, 2025
pulisher
Aug 25, 2025

Published on: 2025-08-26 05:03:52 - 더경남뉴스

Aug 25, 2025
pulisher
Aug 25, 2025

Forecasting Cognition Therapeutics Inc. price range with options data2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Cognition Therapeutics Inc. recovery potential after sell offJuly 2025 Volume & Smart Investment Allocation Insights - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Is Cognition Therapeutics Inc. building a consolidation baseWeekly Stock Report & High Accuracy Swing Entry Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

How Cognition Therapeutics Inc. stock performs during market volatility2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Cognition Therapeutics Inc. stock trend forecastMarket Growth Review & Consistent Profit Trading Strategies - Newser

Aug 24, 2025
pulisher
Aug 23, 2025

Support Zone Holds Steady for Cognition Therapeutics Inc. After DipJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Cognition Therapeutics Inc. Reaches Critical Trendline SupportPortfolio Gains Report & Low Drawdown Investment Ideas - beatles.ru

Aug 23, 2025
pulisher
Aug 22, 2025

Cognition Therapeutics Inc. Stock Lags Behind Sector BenchmarksWatch List & Verified Momentum Stock Watchlist - 더경남뉴스

Aug 22, 2025
pulisher
Aug 22, 2025

Cognition Therapeutics shares rise 2.51% premarket after Silo Pharma's Alzheimer's candidate SPC-14 featured in Alzheimer’s Research & Therapy. - AInvest

Aug 22, 2025
pulisher
Aug 22, 2025

Cognition Therapeutics Inc. stock outlook for YEAR2025 Volatility Report & AI Powered Trade Plan Recommendations - Newser

Aug 22, 2025
pulisher
Aug 21, 2025

Technical Models Suggest Cognition Therapeutics Inc. May Rebound SoonJuly 2025 Earnings & Reliable Intraday Trade Alerts - 더경남뉴스

Aug 21, 2025
pulisher
Aug 21, 2025

Applying Elliott Wave Theory to Cognition Therapeutics Inc.Gold Moves & Short-Term Swing Trade Alerts - Newser

Aug 21, 2025
pulisher
Aug 21, 2025

Cognition Therapeutics shares rise 1.93% intraday after Nature Aging study links FTL1 protein reduction to reversing age-related memory loss. - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Cognition Therapeutics shares rise 14.60% intraday after Nature Aging study shows potential for reversing age-related memory loss and company's expansion of zervimesine treatment for Lewy body dementia. - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

What makes Cognition Therapeutics Inc. stock price move sharplyQuarterly Earnings Summary & Long-Term Safe Investment Ideas - Newser

Aug 21, 2025
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):